#04 DELIVER ON TARGET AVOID HARMING THE GOOD CELLS, BY TARGETING
“LOW PRODUCTION COST THROUGH BATCH HOMOGENEITY
✔️ Homogeneous production (DAR and positioning of the drug conjugation site on the antibody)
✔️ No genetic engineering, no risk of rejection or reduced efficiency.
✔️ Versatility in the choice of :
- DAR
- Positioning
- Type of payload, antibody and linker
“WASSC'S platforms are the solution to optimize your bioactive molecules & solve your issues
#1 wassc's ACCELERATE
WASSC’S Accelerate the development of innovative treatment by offering a unique opportunity to produce the next generation of ADC and Vaccine by using its bioconjugation screening platform and drug/linker design platform.
#2 wassc's DEVELOP
WASSC’S Develop new delivery system based on simplest and tunable nanoemulsion system and hydrogel technologies useful for topic, oral and other administration mode.
#3 wassc's CREATE
WASSC’S Create a multidisciplinary team built with different expertise and experiences that allow us to approach science in a different way to obtain the most out of each project
